| Windsor Health And Rehabilitation Center, Llc | |
| 581 Poquonock Ave, Windsor, Connecticut 06095 | |
| (860) 688-7211 | |
| Name | Windsor Health And Rehabilitation Center, Llc |
|---|---|
| Location | 581 Poquonock Ave, Windsor, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 108 |
| Occupancy Rate | 81.2% |
| Medicare ID (CCN) | 075011 |
| Legal Business Name | Windsor Health And Rehabilitation Center Llc |
| Ownership Type | For Profit - Individual |
| NPI Number | 1568620045 |
| Address | 581 Poquonock Ave, Windsor, CT 06095 |
| Phone Number | 860-688-7211 |
News Archive
Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System (MNS).
NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.
A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
› Verified 7 days ago
| NPI Number | 1770950495 |
| Organization Name | WINDSOR HEALTH AND REHABILITATION CENTER, LLC |
| Address | 581 Poquonock Ave, Windsor, CT 06095 |
| Phone Number | 860-688-7211 |
News Archive
Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System (MNS).
NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.
A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System (MNS).
NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.
A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $13905 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.57 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.6 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.77 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.19 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.75 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.25 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.79 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.08 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.97 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.65 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.45 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 12.06 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.18 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 77.31 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.84 | 82.93 |
News Archive
Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for use in the Niobe Magnetic Navigation System (MNS).
NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.
A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.
Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
› Verified 7 days ago
Windsor Health And Rehabilitation Center, Llc Location: 581 Poquonock Ave, Windsor, Connecticut 06095 Phone: (860) 688-7211 | |
Kimberly Hall-south Center Location: 1 Emerson Drive, Windsor, Connecticut 06095 Phone: (860) 688-6443 | |